Objective To investigate whether the mortality gap has reduced in recent years between people with schizophrenia or bipolar disorder and the general population.
Introduction
Schizophrenia has been described as a life shortening condition, 1 and many studies have shown that people with schizophrenia or bipolar disorder have higher mortality rates than the general population, both as a result of natural [2] [3] [4] [5] [6] [7] [8] [9] [10] and unnatural causes, [2] [3] [4] [5] [6] including suicide. Over the past decade several strategies have been implemented in England and Wales aimed at reducing the mortality gap between people with serious mental illness and the general population, including those to address deliberate self harm and to reduce suicide, [7] [8] [9] to decrease smoking, [10] [11] [12] alcoholism, and drug misuse, 13 14 and to deal with other lifestyles associated with increased mortality. 15 16 Recent studies have suggested that the rate of suicide has been stabilising among people with mental disorders as a whole [17] [18] [19] [20] [21] ; however, trends in mortality for people with schizophrenia or bipolar disorder remain poorly characterised, particularly the relative contributions of natural and unnatural causes. The United Kingdom government's recent mental health strategy states that "more people with mental health problems will have good physical health" as one of its objectives, specifically stating that "fewer people with mental health problems will die prematurely." 22 It is therefore timely to review the level of and trends in these recognised inequalities.
We investigated trends in mortality between 1999 and 2006 during the year after discharge from hospital for people with schizophrenia or bipolar disorder as the principal diagnosis at discharge. We compared mortality in these populations with mortality in the general population of equivalent age in England to determine whether the "mortality gap" between people with these mental disorders and the general population has narrowed in recent years and to describe the relative contributions from natural and unnatural causes of death.
Method Data sources and population included in this study
Our data for analysis came from a linked dataset of English national hospital episode statistics and data from death certification built by the team that developed and manages the Oxford record linkage study. The hospital episode statistics component of the dataset includes statistical abstracts of records of all inpatient episodes undertaken in National Health Service (NHS) trusts in England, including acute hospitals and mental health trusts. Information about deaths came from death certificates held by the Office for National Statistics. This information included the date of death and the causes of death, which were coded by the Office for National Statistics using the ninth and 10th revisions of the international classification of diseases (ICD-9 and ICD-10).
We extracted all records of discharges from inpatient care in England from 1 January 1999 to 31 December 2006 with either schizophrenia (ICD-10 codes F20-29) or bipolar affective disorder (ICD-10 code F31) as the principal diagnosis on the discharge record.
Our primary outcome was mortality within 365 days after psychiatric inpatient care as defined above. We also investigated deaths from unnatural and natural causes. Unnatural deaths were defined on the basis of ICD-10 codes V01-Y98 or ICD-9 codes E800-999 recorded anywhere on the death certificate; the remaining deaths were classified as natural. To allow more detailed interpretation of deaths under these broad categories we have also presented data for deaths from the following specific causes where there were sufficient deaths to provide a stable estimate of risk of mortality-namely, deaths from cardiovascular disease (ICD-10 codes I00-99, ICD-9 codes 390-459), respiratory disease (ICD-10 codes J00-99, ICD-9 codes 460-519), cancer (ICD-10 codes C00-D48, ICD-9 codes 140-239), accidents (ICD-10 codes V01-X59, ICD-9 codes E800-929), and suicide/deaths from undetermined intent (ICD-10 codes X60-89 and Y10-34, ICD-9 codes E950-959 and E980-989).
Analysis
We calculated mortality after hospital discharge as age and sex standardised mortality ratios, comparing mortality in people with schizophrenia or bipolar disorder with mortality in the general population of England. Standardisation was done by using the indirect method, in five year age groups, with the age and sex specific mortality rates of England in the same time periods as the standard. These age and sex specific rates were applied to the age and sex structure of each of the discharge cohorts with schizophrenia or bipolar disorder to calculate an "expected" number of deaths. The observed number was compared with the expected number to calculate the standardised mortality ratios. Its confidence intervals were calculated as described elsewhere. 23 We further compared the mortality rates in three broad age groups: <45, 45-64, and 65-84 (with age standardisation, as above, using five year age groups within each truncated broader age group). We excluded analysis of those aged over 85 because of small numbers.
We used the Poisson test of trend to investigate whether there was a significant trend in standardised mortality ratios over time. 24 
Results

Trends in discharges with schizophrenia and bipolar disorder
For this study we included 100 851 discharges from hospital for bipolar disorder and 272 248 discharges for schizophrenia in England for [1999] [2000] [2001] [2002] [2003] [2004] [2005] [2006] . Tables 1⇓ and 2⇓ show the basic demographic characteristics of the populations. Over the course of the study, the total number of discharges for bipolar disorder decreased by 3.9% from 12 369 to 11 888 (table 1) and the total number of discharges for schizophrenia decreased by 10.9% from 35 348 to 31 486 (table 2) . About three in four of the deaths in each of the two cohorts were from natural causes.
Standardised mortality ratios for schizophrenia and bipolar disorder
Age and sex standardised mortality ratios in the psychiatric cohorts were about double the population average. For example, in the 2006 cohort the ratio was 2.2 in the population discharged with schizophrenia and 1.9 in the population discharged with bipolar disorder. Standardised mortality ratios were higher in younger than in older people: in those aged under 45 discharged in 2006, the ratios were 6.2 (95% confidence interval 4.9 to 7.5) for schizophrenia and 3.4 (1.7 to 5.1) for bipolar disorder compared with 2.0 (1.7 to 2.3) and 1.8 (1.4 to 2.2), respectively, in people aged 65-84 (tables 3⇓ and 4⇓). Men with a discharge diagnosis of schizophrenia had a significantly higher risk of death within the first year than women. For example, in the 2006 cohort the standardised mortality ratio for men was 3.2 (2.8 to 3.6) and 1.8 (1.5 to 2.1) for women (table 4⇓) . There was no significant sex difference in mortality risk for those discharged with a diagnosis of bipolar disorder (table 3⇓).
Trends in mortality ratios
As shown in table 4⇓ and figure 1⇓, standardised mortality ratios for people with schizophrenia increased from 1.6 (1.5 to 1.8) in people discharged in 1999 to 2.2 (2.0 to 2.4) in people discharged in 2006. The Poisson test for trend confirmed that the trend in risk of mortality was significant (P<0.001). For people with bipolar disorder, standardised mortality ratios increased from 1.3 (1.1 to 1.6) in people discharged in 1999 to 1.9 (1.6 to 2.2) in people discharged in 2006 (table 3⇓) . The Poisson test of trend had results of borderline significance (P=0.06). Figures 2 and 3⇓⇓ summarise the data for the people with bipolar disorder or schizophrenia and the general population expressed as rates (to give absolute values). While the mortality rates in the general population tended to decline over time, those in the populations with mental disorders did not. Compared with the mortality rate for the general population, the mortality gap remained fairly stable for adults aged under 65; for those aged 65-84, however, the mortality gap widened during the study period.
Standardised mortality ratios for unnatural/natural causes and specific causes
For unnatural causes, the standardised mortality ratios showed no evidence of a narrowing mortality gap. In people with schizophrenia they were 11.6 (9.5 to 13.7) in the 1999 cohort and 11.6 (9.3 to 13.9) in the 2006 cohort. The corresponding figures for bipolar disorder were 9.3 (6.0 to 12.7) and 12.6 (8.6 to 16.6). Numbers in individual age groups were small, but there was no evidence of a narrowing of the gap in any age group (table 5⇓) .
For natural causes, the mortality gap widened (table 6⇓) . For people with schizophrenia, the standardised mortality ratio was 1.2 (1.1 to 1.4) in the 1999 cohort and 1.7 (1.5 to 1.9) in the 2006 cohort. The corresponding figures for bipolar disorder were 1.1 (0.9 to 1.3) and 1.4 (1.2 to 1.7). Table 7⇓ shows that deaths from cardiovascular disease and respiratory diseases accounted for most of this increase. From 1999 to 2006, in those with schizophrenia, the standardised mortality ratios for circulatory disease rose from 1.6 (1.4 to 1.9) to 2.5 (2.1 to 2.9), while the risk of death from respiratory disease increased from 3.1 (2.6 to 3.6) to 4.7 (3.8 to 5.6). The figures for those discharged with bipolar disorder rose from 1.6 (1.2 to 2.0) to 2.5 (1.9 to 3.1) for circulatory disease and from 3.0 (2.1 to 3.8) to 5.8 (4.3 to 7.3) for respiratory disease.
Discussion Principal findings
The risk of death for people recently discharged from inpatient psychiatric care in England is significantly higher than that in the general population. This excess risk was observed for patients with a diagnosis of schizophrenia and for those with a diagnosis of bipolar disorder. Our findings of a persistent mortality gap in England in patients discharged between 1999 and 2006 are similar to results recently published by Tiihonen et al on all cause mortality in people with schizophrenia over a similar time period in Finland. 25 26 Additionally, our findings suggest that the differential mortality for people with schizophrenia has widened in some groups, a result that is similar to the findings from a systematic review by Saha et al in 2007. 27 Much of the increase in mortality is attributable to deaths from natural causes, especially circulatory disease and respiratory disease. Our findings support the recommendation of Saha et al that "in light of the potential for second-generation antipsychotic medications to further adversely influence mortality rates . . . optimizing the general health of people with schizophrenia warrants urgent attention."
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Strengths and weaknesses
Strengths of this study include its large size and the fact that it includes all records of discharges with a diagnosis of schizophrenia or bipolar disorder in the study period and is therefore nationally representative. By linkage to national mortality data we have included comprehensive information on mortality in these vulnerable groups, especially in the period after discharge from hospital when the risk of death is greatest. 2 In addition, to the best of our knowledge, ours are the first published findings on trends in mortality over the past decade for people with bipolar disorder in England, a condition that shares some clinical and management characteristics with schizophrenia. 28 These study characteristics aid the generalisability of our findings compared with previous studies in the UK, which have been limited to case registers within individual mental health trusts. 29 30 To quantify the mortality gap and assess the trend in risk of mortality for people with schizophrenia or bipolar disorder, we calculated standardised mortality ratios, which take into account differences in the age structure of the cases, as well as changes in the underlying mortality rates of the general population. The widening gap in standardised mortality ratios alone could represent an absolute rise in mortality in the psychiatric population or a fall in mortality in the general population in conjunction with a smaller fall in mortality in the psychiatric population. Accordingly, we have presented rates for all causes of death after discharge compared with national mortality rates over the same period, which allowed us to compare trends in the absolute difference in mortality risk between the groups. Both figures-the standardised mortality ratios and the rates-show that the risk of mortality after discharge is substantial and that the gap in risk, whether calculated in relative or absolute terms, remains substantial. The standardised mortality ratios for schizophrenia and bipolar disorder towards the end of this observation period are similar to those recently reported from the South London and Maudsley Biomedical Research Centre psychiatric case register for 2007-9, which also found a similarly pronounced excess in younger patients. 29 Potential limitations include the usual caveats concerning the use of routinely collected data, including information from hospital records and death certificates, which are not collected for research purposes. [31] [32] [33] [34] There are also caveats about the validity of a dichotomy between "natural" and "unnatural" categories of death, although the definitions of these categories from the ICD codes were standard. 35 36 The case groups consisted of people who had been recently admitted to hospital with a principal diagnosis of a mental disorder during the period in question and cannot be said to represent all people with the disorders; they are likely to represent a more severely affected group at a period of higher risk. The severity of the disorders in the case groups might have changed over the monitoring period because of changes in admission policy. Keown et al found little evidence of any significant decrease in admissions for schizophrenia or bipolar disorder during this period, 37 and our finding of minor reductions in discharges over the observation period compared with the increases in standardised mortality ratios suggests that the concentration of mortality risk in these patients admitted to hospital is unlikely to be the sole explanation for the widening mortality gap, although residual confounding with severity of illness cannot be excluded entirely.
Interpretation, unanswered questions, and need for further work
Schizophrenia and bipolar disorder are known to be associated with a higher risk of mortality.
1 Over the past decade the contribution of natural causes to excess mortality in people with severe mental illness has been increasingly recognised, particularly the impact of coronary heart disease, stroke, and cancer. 38 For example, Osborn and colleagues used information from the UK General Practice Research Database to follow up a community sample of people with severe mental illness and found that these people had a significantly increased risk of death from coronary heart disease and stroke compared with controls that was not wholly explained by antipsychotic medication, smoking, or social deprivation. 39 While knowledge about the specific causes of death in severe mental illness are becoming clearer, the pathogenic mechanisms that culminate in higher than expected mortality from natural causes in people with mental disorder are little understood and likely to be complex. 40 41 Mechanisms acting through the direct effects of symptoms of mental disorder are unlikely to have a large effect on mortality from natural causes, although they are likely to influence death from suicide and other unnatural causes. 42 Premature deaths from natural causes are likely to be influenced by adverse lifestyle and social factors associated with the presence of mental illness-such as smoking, use of alcohol and illicit drugs, and exposure to poor housing and social conditions 40 43 -or the adverse effects of antipsychotic medication. 44 45 It has been suggested, however, that these factors do not account for all the excess mortality, 39 and there is an urgent need for more research to understand the contribution of the six leading global risk factors for mortality identified by WHO-namely, hypertension, smoking, raised glucose concentration, physical inactivity, overweight and obesity, and high cholesterol concentration-to excess mortality in people with severe mental illness, including schizophrenia and bipolar disorder. 41 Our results reinforce the need for further research in the UK as the mortality gap has not decreased and is increasing in some groups, such as those aged over 65. These results have particular policy relevance in the context of the implementation of the new national mental health strategy in England. They strongly point to the need for continued action to target risk factors for both natural and unnatural causes of death, including known risk factors for circulatory and respiratory disease, particularly to lower the risk for these people in the year after discharge from hospital. It is encouraging that the government has recognised and prioritised the importance of preventing premature mortality in its recently published mental health strategy. 22 A reduction of the gap is also a challenge for the forthcoming reorganisation of the NHS in England, for general practitioner commissioning, and for the reorganisation's emphasis on an NHS driven by outcomes. The already widening mortality gap between people with schizophrenia or bipolar disorder and the general population, however, suggests that these policies might be challenging aspirations.
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What is already known on this topic
People with schizophrenia or bipolar disorder have higher mortality rates than the general population, both as a result of natural and unnatural causes Recent evidence suggests that the rate of suicide and death from unnatural causes has been stabilising among people with mental illness in the UK The English government's recent mental health strategy has stated clearly that "fewer people with mental health problems will die prematurely"
What this study adds
The mortality gap between people with schizophrenia or bipolar disorder who have been recently discharged from hospital and the general population persisted between 1999 and 2006 in England For some age groups, such as those aged 65-84, the mortality gap has increased Most of this excess mortality was the result of deaths from natural causes, especially deaths from circulatory and respiratory diseases 
